Literature DB >> 10944083

Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia.

F M Belgore, G Y Lip, A D Blann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10944083     DOI： 10.1016/s0021-9150(00)00477-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  3 in total

1.  A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.

Authors:  Maria G Stathopoulou; Amélie Bonnefond; Ndeye Coumba Ndiaye; Mohsen Azimi-Nezhad; Said El Shamieh; Abdelsalam Saleh; Marc Rancier; Gerard Siest; John Lamont; Peter Fitzgerald; Sophie Visvikis-Siest
Journal:  J Lipid Res       Date:  2012-12-02       Impact factor: 5.922

2.  Effect of co-administration of morphine and nicotine on cardiovascular function in two-kidney one clip hypertensive (2K1C) rats.

Authors:  Motahareh Zeinivand; Mohammad Reza Rahmani; Mohammad Allatavakoli; Ali Shamsizadeh; Gholamhossin Hassanshahi; Hossien Rezazadeh; Ali Asghar Pourshanazari
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

3.  Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.

Authors:  N A Chung; C Lydakis; F Belgore; F L Li-Saw-Hee; A D Blann; G Y H Lip
Journal:  Heart       Date:  2003-12       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.